Maryland's Defense Patent Database

The defense community in Maryland is an R&D powerhouse.

Use this database to see the innovative patents that are poised for commercialization.

Methods to protect skeletal muscle against injury

Patent image
AMRMC

Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.

Inventors: 
Liang, Bruce Tsan-tang; Zambraski, Edward John
Patent Number: 
Technical domain: 
Materials and Coatings
FIle Date: 
2008-03-25
Grant Date: 
2011-01-11
Grant time: 
1,022 days
Grant time percentile rank: 
18
Claim count percentile rank: 
6
Citations percentile rank: 
1
'Cited by' percentile rank: 
1
Assignee: 
US ARMY